303 results on '"Büller, Harry R."'
Search Results
2. Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort study
3. Novel insights into weight loss: acupuncture combined with a very low-carbohydrate diet—a Swiss experience
4. Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis
5. Covariate-specific ROC curve analysis can accommodate differences between covariate subgroups in the evaluation of diagnostic accuracy
6. Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction
7. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study
8. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
9. Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients
10. Upper Extremity Deep Vein Thrombosis
11. Evaluation of markers of fibrinolysis and coagulation in pregnant women with human immunodeficiency virus
12. Interrater agreement of two scales on the severity of anticoagulant-related major bleeding in patients with venous thromboembolism
13. Profile of antiphospholipid antibodies in HIV‐infected and HIV‐uninfected women with a history of thrombosis
14. Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups
15. Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysis
16. Evaluation of Markers of Fibrinolysis and Coagulation in Pregnant Women with Human Immunodeficiency Virus
17. Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
18. Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban
19. von Willebrand factor propeptide‐to‐antigen ratio in HIV‐infected pregnancy: Evidence of endothelial activation
20. Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis
21. Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study
22. Abelacimab for Prevention of Venous Thromboembolism
23. Pulmonary embolism at autopsy in cancer patients
24. Arterial Thromboembolism in Cancer Patients
25. Obituary J. W. ten Cate
26. Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal
27. Pregnancy‐related venous thromboembolism and HIV infection
28. Venous Thromboembolism
29. New Heparins: Synthetic Pentasaccharides
30. Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism: Rationale and design of the PLATO-VTE study
31. Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study
32. d-Dimer and COVID-19
33. Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases
34. d-Dimer and COVID-19
35. Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis
36. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis
37. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands
38. Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta‐analysis
39. Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
40. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta‐analysis
41. Diagnostic and Therapeutic Management of Upper Extremity Deep Vein Thrombosis
42. Development of a standardized definition of pulmonary embolism‐related death: A cross‐sectional survey of international thrombosis experts
43. Definition of pulmonary embolism‐related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH
44. The intestinal microbiome potentially affects thrombin generation in human subjects
45. Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis
46. Clinical implications of incidental venous thromboembolism in cancer patients
47. The Ottawa score performs poorly in cancer patients with incidental pulmonary embolism
48. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
49. Follow‐up to comment on “Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: Systematic Review and Meta‐Analysis”
50. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta‐analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.